Welcome to the e-CCO Library!

P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T.L. PARIGI, G. Roda PhD, M. Allocca, F. Furfaro, L. Loy, A. Zilli, S. Bonovas, S. Danese, G. Fiorino

Created: Thursday, 30 January 2020, 10:12 AM
P747: A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Chowers1, N. Asayag*2, N. Dan3, G. Focht3, R. Balicer4, E. Zittan4, E. Matz5, I. Brufman4, B. Feldman4, A. Cahan6, N. Lederman7, I. Dotan4, E. Israeli8, D. Turner3

Created: Friday, 22 February 2019, 9:41 AM
P747: Extracolonic and colonic cancer risk in patients with ulcerative colitis and primary sclerosing cholangitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Jelaković M.*1, Brinar M.1,2, Turk N.1, Prijić R.1, Krznarić Z.1,2, Rustemović N.1,2, Cukovic-Cavka S.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P747: Predictors of thiopurine treatment failure in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.H. Hwang1*, J.S. Koo1, K.H. Kang1, D.-w. Lee1, B.J. Lee2, Y.T. Jeen3

Created: Thursday, 21 February 2019, 9:14 AM
P747: The impact of COVID-19 on patients with Inflammatory Bowel Disease: A population-based study using artificial intelligence.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moralejo Lozano, Ó.(1)*;Beneyto Martín, P.(2);Abanades Tercero, M.(1);Muñoz Rosas, C.(1);Ruano Díaz, L.(1);Salmoral Luque, R.(1);Gómez Rodríguez, R.(1);
Created: Friday, 14 July 2023, 11:12 AM
P748 Characteristics of inflammatory bowel diseases in different stage of adolescence
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K.J. Szántó1, A. Bálint1, R. Bor1, A. Fábián1, Á. Milassin1, M. Rutka1, Z. Szepes1, N. Vass2, T. Molnár1, K. Farkas1

Created: Thursday, 30 January 2020, 10:12 AM
P748: Clinical outcomes and prognostic factors of methotrexate therapy in combination with anti-TNF agents in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Park1,2*, J.H. Cheon1,2, J.J. Park3, Y. Park1,2, S.J. Park1,2, T.I. Kim1,2, W.H. Kim1,2

Created: Thursday, 21 February 2019, 9:14 AM
P748: High stress and significant decrease in productivity in caregivers of IBD patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zand A., Kim B.D., Dvorsky M., Hommes D.W.

Created: Wednesday, 20 February 2019, 10:36 AM
P748: Pharmacokinetics, relative bioavailability, and dose proportionality of a tablet formulation of the sphingosine 1-phosphate-1 receptor modulator VTX002 (formerly OPL-002)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gregg, R.(1);Yun, C.(1)*;Naik, S.(1);Huyghe, M.(2);Harris, J.(2);Mohan, R.(1);Nuss, J.(1);Sandborn, W.J.(1);
Created: Friday, 14 July 2023, 11:12 AM
P748: Retrospective study on incidence rates of NAFLD and advanced liver fibrosis in Crohn's disease and ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. Domislovic*1, I. Knezevic Stromar1, M. Premuzic1, D. Vranesic Bender2,3, M. Matasin4, A. Milinkovic4, I. Mikolasevic5,6, Z. Krznaric1,2,4

Created: Friday, 22 February 2019, 9:41 AM
P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn’s colitis organisation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.K. Yamamoto-Furusho1, N.N. Parra-Holguín2, E. Grupo-Colombiano3, F. Bosques-Padilla4, G. Veitia-Velásquez5, E. Torres6, F. Piñol-Jiménez7, S. Bautista8, A. Frías-Santana9, K. Villa-Ovalles8, G. Otoya-Moreno10, B. Iadé-Vergara11, EPILATAM-Study Group

Created: Thursday, 30 January 2020, 10:12 AM
P749: A comparative analysis of low bioavailability steroids in inducing clinical response and remission in ulcerative colitis: Budesonide MMX as the safest option
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Scrivo, E. Giuffrida, V. Calvaruso, M. Cappello*

Created: Thursday, 21 February 2019, 9:14 AM
P749: Crohn's disease stricture response and resolution with adalimumab therapy demonstrated with intestinal ultrasound. The STRIDENT randomised trial.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lovett, G.(1,2)*;Schulberg, J.D.(1,2);Hamilton, A.L.(1,2);Wright, E.K.(1,2);Sutherland, T.R.(2,3);Kamm, M.A.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P749: Early environmental and lifestyle factors are associated with developing inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. van der Sloot*1,2, R. Weersma1, B. Alizadeh2, G. Dijkstra1

Created: Friday, 22 February 2019, 9:41 AM
P749: Impact of psycho-social variables on the activity of inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sarid O.1, Slomin-Nevo V.1, Schwartz D.2, Friger M.3, Sergienko R.3, Chernin E.3, Vardi H.3, Greenberg D.4, Odes S.*5

Created: Wednesday, 20 February 2019, 10:36 AM
P750 Prevalence and characteristics of incidentally diagnosed inflammatory bowel disease during screening colonoscopy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y.M. Han1, J. Lee1, J.P. Im2, J.S. Kim1

Created: Thursday, 30 January 2020, 10:12 AM
P750: Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Mantaka*1, E. Tsoukali2, M. Fragaki3, K. Karmiris3, N. Viazis2, G. Mantzaris2, I. Koutroubakis1

Created: Friday, 22 February 2019, 9:41 AM
P750: Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National U.S. Cohort of U.S. Military Veterans with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hou, J.K.(1)*;Pham, C.(2);Sansgiry, S.(3);Modi, V.(2);Waljee, A.K.(4);
Created: Friday, 14 July 2023, 11:12 AM
P750: Predictors of quick remission after cyclosporine A therapy in Paediatric ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Osiecki*, M. Dadalski, J. Kierkus

Created: Thursday, 21 February 2019, 9:14 AM
P750: Prevalence and risk factors of cholelithiasis in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sturdik I., Krajcovicova A., Leskova Z., Decka R., Cernotova V., Koller T., Huorka M., Hlavaty T.

Created: Wednesday, 20 February 2019, 10:36 AM